Last reviewed · How we verify
NCT06998459
Evaluation of the Effectiveness of Bian-Stone Therapy in Children With Autism Spectrum Disorder
NA trial testing Bian-Stone therapy in Evaluation of Bian Stone Therapy for Autism Spectrum Disorder in 22 participants. Completed in 28 April 2025.
28 April 2025
Quick facts
| Lead sponsor | Taichung Tzu Chi Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 22 |
| Start date | 28 April 2025 |
| Primary completion | 28 April 2025 |
| Estimated completion | 28 April 2025 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Bian-Stone therapy
- Maintain the original treatment approach
Conditions studied
- Evaluation of Bian Stone Therapy for Autism Spectrum Disorder — all drugs for Evaluation of Bian Stone Therapy for Autism Spectrum Disorder →
Sponsor
Taichung Tzu Chi Hospital
Who can join
Adults 18 Months to 6, any sex, with Evaluation of Bian Stone Therapy for Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Autism spectrum disorder (ASD) is a pervasive developmental disorder of brain abnormalities. It presents with difficulties of communication and social interaction, and restrictive interests and restrictive behaviors. The CDC suggested that the popularity of ASD people is 1.5% in the US, and the male to female ratio is 4.5 to 1. In Taiwan, the popularity is around 1%, with the number increasing in recent years. The exact etiology of ASD has remained unknown. Currently, the treatments include behavioral therapies, medication and alternative therapies. However, there is no specific way to cure the core symptoms of ASD. This study plans to apply behavioral therapies and traditional Chinese medical Bian-stone therapies on ASD children and compare the results between ASD children with only behavioral therapies. We will record theAutism Behavior Checklist-Taiwan Version, Development Screening Chart for Children Aged 0-6 Years, and Vineland Adaptive Behavior Scales, Third Edition (Vineland-3) before and after the treatments, and meanwhile using the Ryodoraku Measurement (良導絡) to measure the meridian energy. This study aims to evaluate the effectiveness of traditional Chinese medical Bian-stone therapies in ASD children. In addition, we hope to investigate the relationship between ASD symptoms and twelve meridians and assess the patterns in Chinese medicine. Hopefully this study will help strengthen the clinical evidence in TCM treatments for ASD children and improve the efficacy of this disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06998459
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Taichung Tzu Chi Hospital trials
Trials by the same sponsor.
- NCT06730282 — A Preliminary Study on the Efficacy of Danggui Shaoyao San and Cuscuta Chinensis in Patients with Primary Dysmenorrhea · NA · not yet recruiting
- NCT06998472 — Evaluation of Pediatric Massage in the Treatment of Allergic Rhinitis in Children · NA · completed
- NCT05688267 — Effects of Continuous Mobility Training in Prolonged Mechanical Ventilation · NA · completed
- NCT07178093 — Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization · NA · recruiting
- NCT05858138 — To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06998459 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taichung Tzu Chi Hospital
- Last refreshed: 31 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06998459.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing